Singapore markets closed
Straits Times Index
3,259.14 -33.59 (-1.02%) Nikkei
27,777.90 -448.18 (-1.59%) Hang Seng
18,675.35 -61.09 (-0.33%) FTSE 100
7,556.23 -2.26 (-0.03%) BTC-USD
17,003.54 +71.06 (+0.42%) CMC Crypto 200
404.22 +2.80 (+0.70%)
Orphazyme AS (1TB.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
As of 09:34PM CET. Market open.
| Previous close | 0.1426 |
| Open | 0.1422 |
| Bid | 0.0144 x 0 |
| Ask | 0.2688 x 0 |
| Day's range | 0.1414 - 0.1467 |
| 52-week range | 0.1414 - 2.9000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
- Zacks
Orphazyme (ORPH) Up on Plans of NDA Resubmission for Rare Drug
Orphazyme (ORPH) is looking to resubmit its NDA for arimoclomol to the FDA for the treatment of Niemann-Pick disease type C in the United States. Shares rise.
© 2022 Yahoo. All rights reserved.
